Factors associated with testing of COPD patients for serum AAT levels to detect cases of AATD. The EPOCONSUL study.

G. Vargas Centanaro (MADRID, Spain), J. Rodriguez Hermosa (Madrid, Spain), J. Soriano (Madrid, Spain), J. López- Campos (Sevilla, Spain), J. Soler Cataluña (Valencia , Spain), J. Rodríguez Gonzalez Moro (Granada, Spain), B. Alcázar Navarrete (Madrid, Spain), M. Calle Rubio (Madrid, Spain)

Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Session: COPD phenotypes: a1 antitrypsin deficiency and beyond
Session type: Poster Discussion
Number: 570
Disease area: Airway diseases

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Vargas Centanaro (MADRID, Spain), J. Rodriguez Hermosa (Madrid, Spain), J. Soriano (Madrid, Spain), J. López- Campos (Sevilla, Spain), J. Soler Cataluña (Valencia , Spain), J. Rodríguez Gonzalez Moro (Granada, Spain), B. Alcázar Navarrete (Madrid, Spain), M. Calle Rubio (Madrid, Spain). Factors associated with testing of COPD patients for serum AAT levels to detect cases of AATD. The EPOCONSUL study.. 570

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: